HAVCR2 and neoplasm: While we found the strongest expansion of triple treatment-induced tumor-specific T cells in blood, we also observed substantial expansion of the CD101-negative subset of PD1+TIM3+ TILs, i.e., of transitory cells which are non-terminally differentiated (effector-like) exhausted cells5,51.